RB
Raghubar Bharti
About Raghubar Bharti
Data last updated:
Raghubar Bharti has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Eveksia Pharma Private Limited and Unrogya Pharmacy Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Eveksia Pharma Private Limited at ₹1.02 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eveksia Pharma Private Limited U33110DL2017PTC321810 | Director | 07 Aug 2017 | 2017 | ₹1.02 Cr (FY 2023) | Active |
 Unrogya Pharmacy Private Limited U52520DL2022PTC406138 | Director | 20 Oct 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raghubar Bharti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raghubar Bharti
Raghubar Bharti has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Eveksia Pharma Private Limited and Unrogya Pharmacy Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Eveksia Pharma Private Limited at ₹1.02 Cr (FY 2023).
Raghubar Bharti is associated with 2 companies as Director, including Eveksia Pharma Private Limited (₹1.02 Cr), Unrogya Pharmacy Private Limited.
Raghubar Bharti has expertise in General Business.
Raghubar Bharti has 9 years in corporate governance.
By reported revenue, the largest current company of Raghubar Bharti is Eveksia Pharma Private Limited, with revenue of ₹1.02 Cr (FY 2023).
Raghubar Bharti currently holds positions at 2 companies: Eveksia Pharma Private Limited (₹1.02 Cr), Unrogya Pharmacy Private Limited.